智中國際(06063.HK)預計中期純利減少60%至70%
格隆匯 10 月 23日丨智中國際(06063.HK)公佈,預期集團於截至2020年9月30日止六個月將錄得綜合純利(經撇除中期期間確認的一次性上市開支的影響後)較2019年同期的經審核綜合純利的約24000萬港元(經撇除同期確認的一次性上市開支約590萬港元的影響)減少約60%至70%。
有關減少乃主要由於2019冠狀病毒疫情的持續不利影響導致集團部分正在進行的項目進度放緩,致令中期期間確認的收益及毛利下跌,以及集團其中一個規模較大的項目產生的額外成本,同時亦因公司股份於主板上市而產生的法律及合規成本和專業費用以及公司於香港的主要營業地點搬遷產生的運營及行政開支增加的綜合影響所致。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.